Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:10 Issue:1 Number:7 ISSN#:2563-5476
RCT
ACE Report #12858
Ace Report Cover General Orthopaedics

Peri-Operative Mepivacaine in THA Achieves Earlier Ambulation & Shorter Hospital Stay vs Bupivacaine


How to Cite

OrthoEvidence. Peri-Operative Mepivacaine in THA Achieves Earlier Ambulation & Shorter Hospital Stay vs Bupivacaine. ACE Report. 2021;10(1):7. Available from: https://myorthoevidene.com/AceReport/Report/12858

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Mepivacaine versus Bupivacaine Spinal Anesthesia for Early Postoperative Ambulation

Anesthesiology. 2020 Oct 1;133(4):801-811.

Contributing Authors: Schwenk ES Kasper VP Smoker JD Mendelson AM Austin MS Brown SA Hozack WJ Cohen AJ Li JJ Wahal CS Baratta JL Torjman MC Nemeth AC Czerwinski EE

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and fifty-nine patients scheduled for a primary total hip arthroplasty were randomized to receive spinal anesthesia with hyperbaric bupivacaine (n=54), isobaric bupivacaine (n=52), or mepivacaine (n=53). Primary outcome of interest was the percentage of patients achieving ambulation within 3-3.5 hours. Secondary outcomes of interest included the time to motor function return, initial d...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.